Understanding Carevive SMART Data™

In a world inundated with vast amounts of healthcare data, making sense of it all can be overwhelming. The questions arise – how do we determine what’s meaningful and actionable amidst the sea of information from various sources?

Enter Carevive SMART Data, a game-changer that helps healthcare professionals extract valuable insights from disparate treatment options, drug dosages, interactions, and care delivery data. This digital oncology platform combines EHR-derived clinical data and longitudinal patient-reported outcomes, creating a comprehensive picture of symptoms, disease, and treatment response.

One remarkable example of its utility lies in improved transparency across the care team. Physicians can seamlessly access discrete ePROs data, track trends, and gauge symptom severity, while the nursing team receives proactive notifications, empowering them to engage with patients in real-time and offer personalized care.

Carevive SMART Data streamlines the patient-care team interaction, reducing severe symptoms, hospitalizations, and ultimately improving patient outcomes. By sifting through and identifying the most relevant and actionable data, Carevive SMART Data elevates healthcare decision-making to a whole new level.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…